Effect of Caesalpinia bonducella seed extract on histoarchitecture of some vital organs and clinical chemistry in female albino rats  by Lilaram,  & Nazeer Ahamed, R.
Journal of King Saud University – Science (2013) 25, 1–6King Saud University
Journal of King Saud University –
Science
www.ksu.edu.sa
www.sciencedirect.comORIGINAL ARTICLEEﬀect of Caesalpinia bonducella seed extract on
histoarchitecture of some vital organs and clinical
chemistry in female albino ratsLilaram, R. Nazeer Ahamed *Department of Post Graduate Studies and Research in Zoology, Karnatak University, Dharwad, Karnataka, IndiaReceived 24 March 2012; accepted 24 September 2012
Available online 13 October 2012*
E
10
El
Pe
doKEYWORDS
Caesalpinia bonducella;
Clinical chemistry;
Histoarchitecture;
Vital organs;
Albino ratsCorresponding author. Tel.
-mail address: drnazeerahm
18-3647 ª 2012 King Saud
sevier B.V. All rights reserve
er review under responsibilit
i:http://dx.doi.org/10.1016/j.
Production and h: +91 83
ed@yaho
Universit
d.
y of King
jksus.201
osting by EAbstract The effect of an ethanolic seed extract of Caesalpinia bonducella F., (Caesalpiniaceae) on
the histoarchitecture of the some vital organs and clinical chemistry was evaluated in Wistar female
albino rats. The study was divided into four groups. Group I received distilled water and served as
vehicle treated control. Groups II, III and IV were orally administered 100, 200 and 300 mg/kg b.wt
dose of seed extract respectively for 10 consecutive days and subsequently euthanized twenty four
hours after the last dose. Histoarchitecture of the vital tissues in treated groups appeared normal.
Hematological analysis showed a signiﬁcant increase in RBC count, various types of WBCs, platelet
count, hemoglobin levels and packed cell volume levels in all the seed extract treated groups. Serum
biochemistry revealed signiﬁcantly decreased cholesterol, triglycerides and creatinine levels whereas
HDL level was found to be signiﬁcantly increased in all the treated groups. Our results suggest that
the ethanolic seed extract of C. bonducella probably possesses chemical constituents of cytoprotec-
tive potential and should be further explored as a source of natural medicine.
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lsevier1. Introduction
Herbs have attracted attention as a potential natural health
care approach that focuses on protecting and restoring the
health (Badakhshan et al., 2011). Recently herbal medicines
are being increasingly utilized to treat a wide variety of clinical
diseases, with relatively little knowledge regarding their modes
of action. India is sitting on a gold mine of well-recorded and
traditionally well-practiced knowledge of herbal medicines;
therefore, any scientiﬁc data on such plant derivatives in order
to determine the toxic or beneﬁciary effects when used for a
short or long period of time as food or medicine to various tis-
sues and organs could be of clinical importance (Desai, 2005).
Caesalpinia bonducella F., (Caesalpiniaceae) commonly
known as Nata Karanja, is a prickly shrub found throughout
2 Lilaram, R. Nazeer Ahamedthe hotter parts of India, Myanmar and Sri Lanka. Seeds con-
sist of a thick, brittle shell with a yellowish white bitter fatty
kernel (Nadkarni, 1954). It is reported to have multiple thera-
peutic properties like adaptogenic and antidiabetic (Kannur
et al., 2006a,b), antitumor (Gupta et al., 2004) antiﬁlarial
(Gaur et al., 2008), immunomodulatory antioxidant (Shukla
et al., 2009a,b), anti-inﬂammatory, antipyretic, analgesic
(Shukla et al., 2010), hypoglycemic, antihyperglycemic, hypo-
lipidemic (Sharma et al., 1997; Chakrabarti et al., 2003), mus-
cle contractile activity (Datte et al., 2004), antimicrobial (Arif
et al., 2009), antifertility (Sukhdev et al., 2011) and diuretic
agent (Khedkar et al., 2011). Its leaf powder is used to treat
gynecological disorders like menorrhagia and leucorrhoea
(Vidyasagar and Prashantkumar, 2007).
The seeds of C. bonducella are found to contain various
chemical constituents such as furanoditerpenes, phytosterinin,
b-sitosterol, ﬂavonoids, bonducellin, aspartic acid, arginine,
citrulline and b-carotene (Williamson, 2002).
Despite its many uses for medicinal purposes, the seed of
this plant has not yet been scientiﬁcally evaluated for its
effect on vital organs by adopting histological procedure in
parallel with clinical chemistry. Therefore, the present study
was conducted to assess its effect on the histoarchitecture of
some vital organs and clinical chemistry in Wistar female albi-
no rats.2. Material and methods
2.1. Plant material
The seeds of C. bonducella F., (Caesalpiniaceae) were procured
from the local market of Dharwad district, Karnataka, India.
Further taxonomic identiﬁcation was conducted by Dr. G.S.
Mulgund and a voucher specimen number Bot/H/484 was
deposited in the Department of Studies and Research in Bot-
any, Karnatak University, Dharwad, India.
2.2. Preparation of the extract
The seed extract was prepared by following the method of Shu-
kla et al. (2009b). Brieﬂy, 50 g powder of C. bonducella was ex-
tracted with 500 ml of 95% ethanol by using a Soxhlet
apparatus for 16 h. The crude extract obtained was ﬁltered
through Whatman paper and the ﬁltrate was evaporated to
dryness on rotary ﬂash evaporator. The yield of the extract
was 4% (w/w). C. bonducella seed extracts (henceforth referred
to as CBSE) obtained were preserved in a sterile glass con-
tainer at 4 C until further use.
2.3. Animal model
Colony bred virgin Wistar female albino rats (Rattus norvegi-
cus), approximately twelve weeks old and weighing between
190 and 200 gm exhibiting regular estrous cycle were housed
in polypropylene cages (35 cm long · 23 cm wide · 15 cm high)
under standard animal house conditions and controlled envi-
ronmental conditions (24 ± 2 C) for 12 h light and 12 h dark-
ness. They were fed pelleted standard rat feed (Sai Durga
Feeds & Foods, Bangalore, India) and allowed free access to
water.2.4. Treatment protocol
Animals were equally distributed into four treatment groups
containing eight animals each. The group I animals were given
distilled water (2 ml/kg b.wt) alone for 10 days and served as a
control group. Groups II, III and IV animals were treated with
CBSE at the dose of 100, 200, 300 mg/kg b.wt /day for 10 con-
secutive days, respectively. The selected tested doses and dura-
tion were based upon the work of Chakrabarti et al. (2003) and
Salunke et al. (2011). The required drug was dissolved in dis-
tilled water and administered orally with a straight ball-tipped
needle.
2.5. Behavioral proﬁle, body and organ weight
The animals were observed daily for behavioral activities
according to the methods of Whishaw et al. (2006). Body
weight was recorded every day during the study period.
Twenty-four hours after the last dose, the rats were weighed
and sacriﬁced under sodium pentobarbital anesthesia (40 mg/
kg). The liver, heart, kidney, adrenal, spleen and pancreas were
carefully dissected out, cleaned off any fat and weighed (abso-
lute weight). The relative organ weight (ROW) of each organ
was then calculated according to the following equation:ROW ¼ Absolute organs weight ðmgÞ=Body weight of rat on
sacrifice day ðgÞ  1002.6. Clinical chemistry
Blood samples were collected by cardiac puncture technique
under sodium pentobarbital anesthesia (40 mg/kg) in sodium
heparin coated tubes. The clinical chemistry parameters viz.
hemoglobin level, RBC count, various types of WBCs count,
platelet count and packed cell volume were analyzed by Swelab
Alfa Mindray 5640 Cell Counter. For serum separation, the
blood was allowed to stand for an hour at room temperature
to clot and then centrifuged at 3000 rpm for 10 min. The super-
natant (serum) was then tipped off into a separate vial and
subsequently subjected to an assessment of cholesterol, triglyc-
erides, high-density lipoprotein, low-density lipoprotein, very
low-density lipoprotein and creatinine levels by Stat Fax
2000: Semi Auto Analyser.
2.7. Histological examination
The tissues were ﬁrst examined for gross pathology and then
ﬁxed in 10% neutral buffered formalin solution. After proper
ﬁxation, the tissues were dehydrated in graded series of alco-
hol, cleared in benzene and embedded in parafﬁn wax. The tis-
sue sections were cut at 5 lm thicknesses by Leica RM 2255
microtome and stained with hematoxylin and eosin. The
stained slides were photographed under Axio Imager M.2
microscope for histological examination.
2.8. Ethical aspects
The study was approved by the Institutional Animal Ethics
Committee, Department of Zoology, Karnatak University,
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Control and Supervision on Experiments on Animals) (Animal
House Registration No. 639/02/a/ CPCSEA) guidelines were
followed for maintenance, use and disposal of the experimental
animals.
2.9. Statistical analysis
One way-ANOVA followed by Tukey’s HSD post hoc multi-
ple comparison tests was employed to analyze data. P values
less than 0.05 were considered signiﬁcant.
3. Results
3.1. Behavioral proﬁle, body and organ weight
There were no treatment related changes in the behavioral
proﬁle at any tested dose level. All animals both in controlTable 1 Effect of Caesalpinia bonducella seed extract on body (g) a
Parameters Vehicle treated control (Group I) 100 mg
Body weight 201.62 ± 2.68 200.37
Liver 3413.81 ± 222.95 3519.46
Adrenal 11.11 ± 0.47 10.93
Kidney 315.56 ± 18.33 313.98
Spleen 246.15 ± 12.02 243.24
Heart 250.47 ± 7.73 250.79
Pancreas 299.50 ± 5.58 302.09
n= 8, data represent mean ± SD. There is no signiﬁcant difference (p 6
Table 2 Effect of Caesalpinia bonducella seed extract on hematolog
Test Vehicle treated control (Group I) 100
Hemoglobin (gms%) 13.68 ± 0.23 1
RBC(million/cumm) 6.87 ± 0.31
WBC(cells/cumm) 4672.87 ± 894.12 501
Platelet(lakhs/cumm) 2.85 ± 0.29
PCV (%) 35.12 ± 0.88 3
Neutrophil (%) 6.37 ± 0.74 2
Lymphocytes (%) 49.87 ± 4.76 5
Eosinophils (%) 3.50 ± 0.53
Monocytes (%) 0.37 ± 0.51
n= 8, data represent mean ± SD.
* Signiﬁcant difference (p 6 0.05) as compared to the control.
Table 3 Effect of Caesalpinia bonducella seed extract on serum bio
Test Vehicle treated control (Group I) 100
Cholesterol (mg/dl) 82.35 ± 1.11 78.
Triglycerides (mg/dl) 113.17 ± 0.97 108.
HDL (mg/dl) 39.08 ± 0.79 40.
LDL (mg/dl) 20.62 ± 1.02 16.
VLDL(mg/dl) 22.63 ± 0.19 21.
Creatinine(mg/dl) 1.57 ± 0.04 1.
n= 8, data represent mean ± SD.
* Signiﬁcant difference (p 6 0.05) as compared to the control.and extract treated groups appeared healthy, alert and were
responding to pain and touch. No signiﬁcant difference was
observed in the body and relative organ weight in seed extract
treated groups when compared with vehicle treated group
(Table 1).
3.2. Hematolgy
The results of hematological analysis are presented in Table 2.
The value of hemoglobin level showed a signiﬁcant increase
(p 6 0.05) at 300 mg/kg dose level when compared with vehicle
treated control group. RBC and WBC counts showed a signif-
icant increase (p 6 0.05) at 200 and 300 mg/kg dose when com-
pared with their respective vehicle treated control group.
Platelet count and PCV levels increased signiﬁcantly
(p 6 0.05) in a dose dependant manner in all the extract treated
groups. Neutrophil, lymphocyte and eosinophils percent were
also signiﬁcantly increased (p 6 0.05) in a dose dependantnd relative organ weight per 100 g b.wt (mg).
(Group II) 200 mg (Group III) 300 mg (Group IV)
± 3.67 202.36 ± 2.79 201.66 ± 2.47
± 259.44 3242.59 ± 259.63 3214.76 ± 221.45
± 0.57 11.3 ± 1.61 10.32 ± 0.72
± 20.78 321.33 ± 12.66 310.62 ± 9.02
± 18.81 240.13 ± 25.32 247.16 ± 11.27
± 7.15 253.26 ± 8.23 247.39 ± 8.93
± 12.02 302.49 ± 7.46 298.17 ± 3.69
0.05) between the groups.
ical parameters.
mg (Group II) 200 mg (Group III) 300 mg (Group IV)
3.62 ± 0.30 13.81 ± 0.24 14.55 ± 0.15*
6.68 ± 0.37 7.38 ± 0.25* 7.65 ± 0.12*
7.50 ± 415.47 5586.25 ± 208.45* 7915.62 ± 69.52*
4.20 ± 0.37* 4.26 ± 0.14* 5.54 ± 0.52*
6.62 ± 1.02* 38.86 ± 1.21* 40.60 ± 0.96*
3.50 ± 0.75* 36.25 ± 0.88 * 48.62 ± 5.04*
4.50 ± 0.92* 67.25 ± 1.28* 86.50 ± 1.51*
4.62 ± 0.51* 4.87 ± 0.64* 4.87 ± 0.83*
0.50 ± 0.53 0.62 ± 0.51 2.75 ± 0.70*
chemistry.
mg (Group II) 200 mg (Group III) 300 mg (Group IV)
11 ± 1.06* 70.37 ± 1.40* 53.12 ± 1.55*
25 ± 1.90* 99.73 ± 1.53* 98.37 ± 0.51*
18 ± 0.71 40.50 ± 2.07 42.21 ± 0.67*
28 ± 1.39* 8.21 ± 1.03* 7.05 ± 0.62*
65 ± 0.38 19.94 ± 0.30* 19.67 ± 0.10*
40 ± 0.09* 0.95 ± 0.13* 0.56 ± 0.05*
4 Lilaram, R. Nazeer Ahamedmanner in seed extract treated when compared with vehicle
treated group. Monocyte percent elevated signiﬁcantly
(p 6 0.05) at a dose level of 300 mg/kg b.wt.
3.3. Serum biochemistry
The results of serum biochemical analysis are presented in Ta-
ble 3. There was a signiﬁcant decrease (p 6 0.05) in the choles-
terol and triglycerides levels in a dose-dependent manner in all
the seed extract treated groups when compared to that in their
respective vehicle treated groups. The HDL level showed a sig-Figure 1 Histoarchitecture of the vital organs of female rats of v
bonducella seed extract at the doses 100, 200, 300 mg/kg b.wt for 10 da
chromafﬁn cell, G-glomerulus, DT-distal tubule, PT-proximal tubule, R
intercalated disk, N-nucleus, bc-beta cells, bn-basal nucleus, IS-interloniﬁcant increase (p 6 0.05) at 200 mg/kg b.wt. dose level. No
signiﬁcant changes were noticed in LDL and VLDL levels.
The value of creatinine showed a signiﬁcant decrease
(p 6 0.05) in a dose-dependent manner in the seed extract
group when compared to the vehicle treated group.
3.4. Histological observations
The light microscopy examinations of vital organs are pre-
sented in Fig. 1. The liver of normal control animals showed
complete hepatic lobules with well formed hepatocytes withehicle treated control and following treatment with Caesalpinia
ys. Abbreviation-CV-central vein, H-hepatocyte, S-sinusoids, CC-
P-red Pulp, F-follicle, MZ-marginal zone, MS-marginal sinus, ID-
bular septa, LA-lobular acini.
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fashion, separated by sinusoids and central vein were seen
clearly (Fig. 1a). These structures were also found intact in
all extract treated animals (Fig. 1b–d). Chromafﬁn cells and
sinusoid areas of the medulla region of adrenal gland were de-
void of any treatment related alteration (Fig. 1e-h). Kidney
(Fig. 1i-l), spleen (Fig. 1m-p) and heart (Fig. 1q-t) showed
no evidence of vacuolations or distortion in all tested doses
when compared with vehicle treated control. The beta cells
of endocrine pancreas seemed to proliferate in treated group
over the vehicle treated group. Exocrine pancreas showed no
evidence of deformation (Fig. 1u-x).4. Discussion
Considering the complexity of herbals in general and their
inherent biological variation, it is now necessary to evaluate
their safety, efﬁcacy and quality (Castro et al., 2009). In the
present study, we investigated the effect of oral administration
of CBSE for 10 consecutive days. There were no noticeable
changes in the behavioral proﬁle, body, organ weights and
gross pathology of vital organs at all tested dose levels. These
records can be considered as a part of pharmacological effects
of herbs but not as toxicological signs. The research ﬁnding of
Sagar and Vidyasagar (2010) is in favor of the present investi-
gation where administration of ethyl acetate extract of C.
bonducella leaves at a dose level of 166.7 and 250 mg/kg b.wt
in albino mice for ﬁfteen days did not produce marked changes
in various clinical parameters and organ weight except liver at
250 mg/kg b.wt. Moreover, Gupta et al. (2004) have also sup-
ported the present study where the treatment of methanolic
leaf extract of C. bonducella against Ehrlich ascites carcinoma
in Swiss albino mice did not produce any signiﬁcant change in
the weight of liver, kidney, brain and spleen at 50, 100, 200 and
300 mg/kg b.wt in fourteen days of treatment.
Histological studies play an important role in anatomical
localization of toxic/beneﬁcial action of various phytochemi-
cals. In the present study, liver showed intact hepatocytes, cen-
tral vein and sinusoids in all the seed treated animals. A
number of scientiﬁc reports indicated certain ﬂavonoids, trit-
erpenoids and steroids have a protective effect on the liver
due to their antioxidant properties (DeFeudis et al., 2003;
Takeoka and Dao, 2003). Therefore, the presence of these phy-
tochemicals in ethanolic seed extract of C. bonducella rules out
any possibility of degenerative changes in liver histoarchitec-
ture, in the present study. Moreover, Sambath et al. (2010)
have also reported hepatoprotective and antioxidant effects
of C. bonducella on carbon tetrachloride-induced liver injury
in rats at 50, 100 and 200 mg/kg b.wt for 10 days.
Histoarchitecture of medulla of adrenal gland also indi-
cated that the seed extract does not have an adverse effect in
treated animals. This is probably due to adaptogenic potential
(Kannur et al., 2006a) of C. bonducella seed extract.
The signiﬁcant decrease in the creatinine level and well or-
ganized glomerulus, proximal and distal tubule in seed extract
animals clearly indicate that the kidneys were working efﬁ-
ciently in extract treated animal. Khedkar et al. (2011) have
also reported diuretic effects of C. bonducella seed extracts
with a dose-dependent increase in urine excretion and speciﬁc
conductivity at dose levels of 150 and 300 mg/kg b.wt in rats
and support the present ﬁndings.The signiﬁcant increase in the RBC,WBC, Platelet counts,
hemoglobin, PCV levels in extract treated animals may be
attributed to the immunomodulatory potential of C. bonducel-
la seed extract which could have boosted up the immune sys-
tem and site of hematopoiesis. To strengthen this possibility,
histological analysis of spleen, a site of hematopoiesis in ro-
dents (Cesta, 2006) was carried out. It was found that spleen
exhibited well organized marginal sinus, marginal zone, follicle
with germ center and red pulp region in extract treated ani-
mals. Moreover, Shukla et al. (2009a) have also reported
immunomodulatory potential of ethanolic seed extract of C.
bonducella (200–500 mg/kg b.wt) by oral administration which
evoked a signiﬁcant increase in percent neutrophil adhesion to
nylon ﬁbers as well as a dose-dependent increase in antibody
titer values and potentiated the delayed type hypersensitivity
reaction induced by sheep red blood cells. Also it prevented
myelosuppression in cyclophosphamide drug treated rats and
good responses toward phagocytosis in carbon clearance
assay.
It is a well established fact that the hypertriglyceridemia,
hypercholesterolemia and high LDL levels are major patholog-
ical conditions that contribute to the cardiac cell death. In the
present study, signiﬁcantly decreased levels of cholesterol, tri-
glycerides, LDL and an increased level of HDL in the seed ex-
tract treated animals indicate normal heart function.
Moreover, histoarchitecture of cardiac cells have also exhib-
ited normal intact structure in treated rats and supports the
above fact. Thus, seeds of C. bonducella may be used as a car-
dioprotective agent.
The beta cells in Islet of Langerhans seemed to proliferate
in the seed extract treated groups when compared to vehicle
treated control group. This could be due to the high contents
of ﬂavonoids in seeds of C. bonducella which exhibits high abil-
ity of pancreas b-cell regeneration (Szkudelski, 2001). More-
over, Sharma et al. (1997) Chakrabarti et al. (2005) and
Kannur et al. (2006b) have also reported the antidiabetic po-
tential of C. bonducella seed extract in diabetic animal models
at different doses and support the present ﬁnding.
5. Conclusion
The ethanolic seed extract of C. bonducella probably possesses
phytochemicals of cytoprotective nature. Further, extensive
experimental studies should be conducted to establish the exact
mechanism of action and for the isolation and characterization
of the active principle.Acknowledgments
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